BETHESDA, Md., Oct. 26 /PRNewswire-FirstCall/ -- Hanger Orthopedic Group, Inc. announced net sales of $192.3 million for the quarter ended September 30, 2009, an increase of $13.6 million, or 7.6%, from $178.7 million in the prior year. Earnings per share for the third quarter of 2009 were $0.30 per diluted share compared to $0.23 per diluted share for the same period in 2008.
The $13.6 million, or 7.6%, sales increase for the quarter ended September 30, 2009 was primarily the result of a $6.7 million, or 4.3%, increase in same-center sales in our patient care centers, a $2.1 million, or 10.0%, increase in sales of the Company''s distribution segment and a $4.8 million increase principally related to sales from acquired entities. The combination of increased sales and effective expense management resulted in income from operations increasing $3.5 million, or 17.4%, to $23.8 million for the third quarter of 2009, compared to last year.
Net income increased $2.3 million, or 31.4%, to $9.6 million in the third quarter of 2009 from $7.3 million last year. In addition to improved income from operations, net income benefited from lower variable interest cost in the third quarter of 2009.
Net sales for the nine months ended September 30, 2009 increased by $37.4 million, or 7.2%, to $555.0 million from $517.6 million last year. The sales increase was principally the result of a $19.2 million, or 4.3%, increase in same-center sales in our patient care centers, a $5.0 million, or 8.1%, increase in sales of the Company''s distribution segment and a $13.2 million increase principally related to sales from acquired entities.
As was the case for the quarter, the growth in sales and expense management helped increase income from operations by $7.2 million, or 12.9%, to $63.0 million for the nine months ended September 30, 2009 compared to the same period last year. Operating income as a percentage of sales increased to 11.4% for the nine months ended September 30, 2009 compared to 10.8% in the same period of 2008.
Net income applicable to common stock for the nine months ended September 30, 2009 increased by 27.9% to $24.2 million, or $0.76 per diluted share, compared to pro forma net income applicable to common stock of $18.9 million, or $0.60 per diluted share, in the prior year. In addition to improved income from operations, net income benefited from lower variable interest costs during 2009. The pro forma results for the nine months ended September 30, 2008 assume that the one-time, in-kind preferred stock dividend described below occurred and the preferred stock was converted to common stock at the beginning of the period. Net income applicable to common stock for the nine months ended September 30, 2008 on a GAAP basis was $13.2 million, or $0.52 per diluted share.
Cash from operations for the three months ended September 30, 2009 was $25.4 million, a $3.1 million, or 13.9% increase, compared to 2008. The improvement was primarily the result of improved operating results and a $0.8 million decrease in working capital. Days sales outstanding were reduced by 3 days to a record low of 47 days as of September 30, 2009 from 50 days as of September 30, 2008.
As of September 30, 2009, $76.1 million, or 18.6%, of the Company''s total debt of $409.7 million was subject to variable interest rates. The Company had total liquidity of $131.2 million, comprised of $78.4 million of cash and $52.8 million available under its revolving credit facility at September 30, 2009. On October 23, 2009, Barclays Bank replaced $10.0 million of the $17.8 million defaulted Lehman commitment under the revolving credit facility, which increases the current amount available under the credit facility to $62.8 million. The Company believes that it has sufficient liquidity to conduct its normal operations and fund its acquisition plans in 2009.
The Company is reaffirming its full year 2009 sales guidance of $750 to $760 million and increasing its 2009 diluted EPS guidance of $1.02 to $1.04 to $1.05 to $1.07.
"We are very pleased with our third quarter results, as they exceeded our expectations, represented solid operational execution and generated strong cash flow," commented Thomas F. Kirk, President and Chief Executive Officer of Hanger Orthopedic Group. Mr. Kirk added, "Patient care centers revenues grew at 6.6% and our efforts on expense management continue to be reflected in our results. Since the third quarter of last year, we have improved operating margins for the quarter by 100 basis points to 12.4%. We are also extremely pleased with the added commitment to our revolver and liquidity, because it reflects the confidence our lenders have in our consistent execution. I am proud of our teams'' efforts in this economic environment and we are actively monitoring the proposed health care reforms and how they could impact our future prospects."
In June 2008, the Company''s common stock performance triggered an acceleration of preferred stock dividends as a result of the Company''s average closing price of its common stock price exceeding the Company''s forced conversion price of the Series A Convertible Preferred Stock by 200% for a 20-trading day period. This event accelerated the payment of these dividends due from the time of the event through May 26, 2011. The accelerated dividends were paid in the form of increased stated value of preferred stock, in lieu of cash. As a result, the Company recorded an in-kind dividend on its preferred stock of $5.3 million in the quarter ended June 30, 2008, which represented 0.7 million additional common shares on an as-converted basis.
Hanger Orthopedic Group, Inc., headquartered in Bethesda, Maryland, is the world''s premier provider of orthotic and prosthetic patient care services. Hanger is the market leader in the United States, owning and operating 669 patient care centers in 45 states and the District of Columbia, with over 3,700 employees including 1,095 practitioners (as of September 30, 2009). Hanger is organized into four units. The two key operating units are patient care, which consists of nationwide orthotic and prosthetic practice centers, and distribution, which consists of distribution centers managing the supply chain of orthotic and prosthetic componentry to Hanger and third party patient care centers. The third is Linkia, which is the first and only provider network management company for the orthotics and prosthetics industry. The fourth unit, Innovative Neurotronics, introduces emerging neuromuscular technologies developed through independent research in a collaborative effort with industry suppliers worldwide. For more information on Innovative Neurotronics, Inc. or the WalkAide®, visit http://www.ininc.us/. For more information on Hanger, visit http://www.hanger.com/.
This document contains forward-looking statements relating to the Company''s results of operations. The United States Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for certain forward-looking statements. Statements relating to future results of operations in this document reflect the current views of management. However, various risks, uncertainties and contingencies could cause actual results or performance to differ materially from those expressed in, or implied by, these statements, including the Company''s ability to enter into and derive benefits from managed care contracts, the demand for the Company''s orthotic and prosthetic services and products and the other factors identified in the Company''s periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934. The Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.
-tables to follow- Hanger Orthopedic Group, Inc. (Dollars in thousands, except share and per share amounts) (Unaudited) Three Months Ended Nine Months Ended September 30, September 30, Income Statement: 2009 2008 2009 2008 ----------------- ---- ---- ---- ---- Net sales $192,296 $178,742 $554,966 $517,582 Cost of goods sold - materials 58,887 53,411 168,784 155,409 Personnel costs 66,976 63,712 196,783 185,595 Other operating expenses 38,669 37,047 114,085 107,950 Depreciation and amortization 4,002 4,334 12,265 12,805 ----- ----- ------ ------ Income from operations 23,762 20,238 63,049 55,823 Interest expense 7,692 8,005 22,894 24,308 Unrealized gain from interest rate swap - - 167 - -- -- --- -- Income before taxes 16,070 12,233 40,322 31,515 Provision for income taxes 6,428 4,893 16,129 12,606 ----- ----- ------ ------ Net income 9,642 7,340 24,193 18,909 Less preferred stock dividend - Series A Convertible Preferred Stock - - - 5,670 -- -- -- ----- Net income applicable to common stock $9,642 $7,340 $24,193 $13,239 ====== ====== ======= ======= Basic Per Common Share Data: ---------------- Net income $0.31 $0.27 $0.77 $0.54 ===== ===== ===== ===== Shares used to compute basic per common share amounts 31,578,889 27,004,581 31,263,458 24,300,945 ========== ========== ========== ========== Diluted Per Common Share Data: ------------------ Net income $0.30 $0.23 $0.76 $0.52 ===== ===== ===== ===== Shares used to compute diluted per common share amounts 32,214,321 31,990,924 31,938,613 25,399,721 ========== ========== ========== ========== Nine Months Ended September Pro-forma: 30, 2008 ---------- Net income applicable to common stock 13,239 Preferred stock dividend - Series A Convertible Preferred Stock 5,670 ----- Pro-forma net income applicable to common stock $18,909 ======= Diluted Per Share Data: ----------------------- Pro-forma net income per diluted common share $0.60 ===== Shares used to compute diluted per common share amounts 25,399,721 Effects of conversion of convertible preferred stock (1) 6,090,608 --------- Shares used to compute diluted per common share amounts, Pro-forma basis 31,490,329 ========== (1) Assumes Preferred Stock dividend acceleration event occurred January 1, 2008. The Company believes the presentation of the pro-forma results, adjusted for the effects of the acceleration of the Preferred Stock dividend at the beginning of the period, is more reflective of the Company''s current diluted operating results and provides investors with additional useful information to measure the Company''s on-going performance. Three Months Ended Nine Months Ended September 30, September 30, Income Statement as a % of Net Sales: 2009 2008 2009 2008 ------------------- ---- ---- ---- ---- Net sales 100.0% 100.0% 100.0% 100.0% Cost of goods sold - materials 30.6% 29.9% 30.4% 30.0% Personnel costs 34.8% 35.6% 35.4% 35.9% Other operating expenses 20.1% 20.7% 20.6% 20.8% Depreciation and amortization 2.1% 2.4% 2.2% 2.5% --- --- --- --- Income from operations 12.4% 11.4% 11.4% 10.8% Interest expense 4.0% 4.5% 4.1% 4.7% Unrealized gain from interest rate swap 0.0% 0.0% 0.0% 0.0% --- --- --- --- Income before taxes 8.4% 6.9% 7.3% 6.1% Provision for income taxes 3.3% 2.8% 2.9% 2.4% --- --- --- --- Net income 5.1% 4.1% 4.4% 3.7% === === === === Hanger Orthopedic Group, Inc. (Unaudited) Three Months Ended Nine Months Ended September 30, September 30, Cash Flow Data: 2009 2008 2009 2008 --------------- ---- ---- ---- ---- Cash flow from operations $25,388 $22,285 $46,149 $34,855 Capital expenditures $6,577 $4,172 $12,675 $12,012 Increase (decrease) in cash $2,005 $29,571 $19,969 $26,587 Balance Sheet Data: Sept. 30, 2009 Dec. 31, 2008 ------------- -------------- ------------- Cash and cash equivalents $78,382 $58,413 Days Sales Outstanding (DSO''s) 47 51 Working Capital $219,025 $200,248 Total Debt $409,714 $422,324 Shareholders'' Equity $301,264 $266,866 Three Months Ended Nine Months Ended Percentage of September 30, September 30, net sales from: 2009 2008 2009 2008 ---- ---- ---- ---- Patient-care services 87.9% 88.0% 87.9% 87.8% Distribution 12.0% 11.7% 11.9% 11.8% Payor mix: Commercial and other 59.5% 59.4% 59.0% 60.0% Medicare 29.1% 28.8% 29.5% 28.4% Medicaid 6.1% 6.3% 6.2% 6.2% VA 5.3% 5.5% 5.3% 5.4% Statistical Data: Nine Months Ended ----------------- September 30, 2009 2008 ---- ---- Patient-care centers 669 668 Number of practitioners 1,095 1,080 Number of states (including D.C.) 46 46
Hanger Orthopedic Group, Inc.
CONTACT: Thomas F. Kirk, George E. McHenry or Thomas C. Hofmeister, all
of Hanger Orthopedic Group, Inc., +1-301-986-0701
Web Site: http://www.hanger.com/
